ProKidney Corp. Share Price & Technical Analysis
PROK · $1.75 (0.00%)
Healthcare / Biotechnology
$1.75
0.00%
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the develo…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
-5% return in May, 24% avg return in past 3 year May month.
-26% return in 2026, 77% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -13% | 10% | -18% | 0% | -5% | – | – | – | – | – | – | – | -26% |
| 25 | -6% | -25% | -25% | 0% | -22% | -14% | 367% | -8% | 0% | 29% | -29% | 0% | 267% |
| 24 | -24% | 23% | -6% | 24% | 67% | -29% | -8% | 4% | -21% | -16% | 25% | -15% | 25% |
| 23 | 42% | 14% | -2% | -16% | 27% | -8% | 14% | -32% | -47% | -65% | 6% | 6% | -61% |
| 22 | -1% | 0% | 0% | 0% | 0% | 0% | 0% | -2% | -7% | 13% | -12% | -22% | -32% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$523.90M
P/E ratio
—
52W high
$7.13
52W low
$0.54
Volume
4,79,735
Beta
1.75
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ProKidney Corp. share price today?
- ProKidney Corp. (PROK) last traded around $1.75 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PROK have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PROK. Download the app for real-time alerts.
- How can I analyze ProKidney Corp. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.